Does ECULIZUMAB Cause International normalised ratio increased? 39 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of International normalised ratio increased have been filed in association with ECULIZUMAB (SOLIRIS). This represents 0.1% of all adverse event reports for ECULIZUMAB.
39
Reports of International normalised ratio increased with ECULIZUMAB
0.1%
of all ECULIZUMAB reports
4
Deaths
21
Hospitalizations
How Dangerous Is International normalised ratio increased From ECULIZUMAB?
Of the 39 reports, 4 (10.3%) resulted in death, 21 (53.8%) required hospitalization, and 3 (7.7%) were considered life-threatening.
Is International normalised ratio increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ECULIZUMAB. However, 39 reports have been filed with the FAERS database.
What Other Side Effects Does ECULIZUMAB Cause?
Fatigue (4,858)
Off label use (4,228)
Haemoglobin decreased (3,028)
Headache (2,699)
Death (2,221)
Pyrexia (1,948)
Dyspnoea (1,819)
Asthenia (1,732)
Drug ineffective (1,644)
Nausea (1,579)
What Other Drugs Cause International normalised ratio increased?
WARFARIN (5,622)
RIVAROXABAN (863)
ACETAMINOPHEN (533)
ASPIRIN (448)
APIXABAN (317)
CLOPIDOGREL BISULFATE (314)
FLUINDIONE (286)
AMIODARONE (277)
FUROSEMIDE (277)
DABIGATRAN ETEXILATE (223)
Which ECULIZUMAB Alternatives Have Lower International normalised ratio increased Risk?
ECULIZUMAB vs EDARAVONE
ECULIZUMAB vs EDETATE
ECULIZUMAB vs EDOXABAN
ECULIZUMAB vs EDOXABAN TOSILATE
ECULIZUMAB vs EFALIZUMAB